Market revenue in 2023 | USD 10.5 million |
Market revenue in 2030 | USD 16.6 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Topical |
Fastest growing segment | Topical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oral, Topical |
Key market players worldwide | GSK PLC, Abbott Laboratories, Pfizer Inc, Bausch Health Companies Inc, Bayer AG, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Merck & Co Inc, Novartis AG ADR, Sun Pharmaceutical Industries |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to onychomycosis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 57.14% in 2023. Horizon Databook has segmented the Thailand onychomycosis market based on oral, topical covering the revenue growth of each sub-segment from 2018 to 2030.
The Thailand onychomycosis market is anticipated to significantly grow owing to the rising geriatric population across the country. According to an article published by WHO in February 2023, Thailand is among the fastest-aging nations globally, with around 12 million individuals 60 years and above in the country.
Furthermore, the article reports that the country will become a super-aged society by the next decade. Older people are at a higher risk of developing onychomycosis. Thus, the rising geriatric population in Thailand is expected to drive market growth in the coming years.
For instance, in July 2018, a randomized control trial to assess the effectiveness and safety of 1% clotrimazole cream occlusion for treating onychomycosis was performed at Siriraj Hospital, Thailand. Around 30 patients were investigated in this study.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand onychomycosis market , including forecasts for subscribers. This country databook contains high-level insights into Thailand onychomycosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account